Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In this project the investigators study the safety and efficacy of the pipeline embolization device with vantage technology in treatment of unruptured brain aneurysms
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pipeline Embolization Device with Vantage Technology | Device | Flow-diverter device occludes aneurysms through endoluminal reconstruction and remodelling of the parent artery. |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluate 30-day morbidity rates | We will evaluate short term clinical outcome in the form of morbidity rates 30 days after the procedure | Done at 30 days post procedural |
| Evaluate 30-day mortality rates | We will evaluate short term clinical outcome in the form of mortality rates 30 days after the procedure | Done at 30 days post procedural |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluate 1-year morbidity rates | We will evaluate long term clinical outcome in the form of morbidity rates >30days up to 1 year after the procedure | Done at >30days up to 1 year post procedural |
| Evaluate 1-year mortality rates |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients Treated with pipeline embolization devices during 2021 and 2022
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Kings College Hospital | London | United Kingdom |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 31727754 | Background | Atasoy D, Kandasamy N, Hart J, Lynch J, Yang SH, Walsh D, Tolias C, Booth TC. Outcome Study of the Pipeline Embolization Device with Shield Technology in Unruptured Aneurysms (PEDSU). AJNR Am J Neuroradiol. 2019 Dec;40(12):2094-2101. doi: 10.3174/ajnr.A6314. Epub 2019 Nov 14. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002532 | Intracranial Aneurysm |
| D020300 | Intracranial Hemorrhages |
| D020521 | Stroke |
| ID | Term |
|---|---|
| D020765 | Intracranial Arterial Diseases |
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
We will evaluate long term clinical outcome in the form of mortality rates >30days up to 1 year after the procedure
| Done at >30days up to 1 year post procedural |
| D009422 | Nervous System Diseases |
| D000783 | Aneurysm |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D006470 | Hemorrhage |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |